LifeTech

Project overview

LifeTech intends to be an online presentation,

collaboration and investment platform for
longevity and regenerative medicine startups.
Our first priority is to build a presentation site
for industry overview and analytics, followed by
a collaboration network for startups, investors,
and other interested parties.
The plan for later stages is to grow into
investments and crowdfunding solution based
on blockchain and cryptocurrency technologies.

Market overview
Rapid growth of biomedical markets is expected, which means
numerous startups supported by investors.
2

Regenerative medicine is the most promising market:

LifeTech is an online investment platform with a solid analytical

foundation for longevity and regenerative medicine startups.
We intend to use best engineering, fintech, and biomed practices in
this platform.

3D framework
However, many investors find hard to evaluate startups due to the
lack of biomedical knowledge.
3

A feasible solution for this niche must also fill the knowledge gap.

The table below is an example of this holistic overview of startups we

provide for investors.
Neurolog
Reproducti
Cardiovasc
Blood
Diabetes
ical
Wounds ve System
ular
Cancer
Diseases
Disease
Diseases
Disease

Diseases

Organs

Kidney

Liver

Bladder

Cardiovascular Systems

Skin

Ocular
Disease

Gastrointe
stinal
Disease

Pancreas

Trachea

With scaffold

Teeth

Immunolo
gical
Disease

Bones and Cartilage

Without scaffold

Autologous

Allogeneic

Isogeneic

Xenogenic

Connective

Muscle

Epithelial

Nervous

Autologous

Allogeneic

Isogeneic

Xenogenic

Embryonic Stem Cells (ES)

Induced Pluripotent Stem Cells

(iPSC)

Adult Stem Cells

Artificial Cells

Tissues

Cells

Molecular
Induction
Technologies

Genetic Therapy (vectors)

Enabling
Technologies
Services

Muscular and
Skeletal
disorders and
Injuries

Urinary
System
Disease

Equipment

Biobanks

Small molecules and proteins

Reagents and Materials

Clinical Trials

Contract Research
Organization (CRO)

Implants
Contract
Manufacturing (CM)

Combination

Cell and Tissue Sources

Clinics /
Hospitals

Aesthetic
Medicine

Information Systems
Consulting / Legal
Certification

Activity level
Low

Medium

High

For example, the table above shows that BioTime Inc:

focuses primarily on cancer and neurological diseases with some attention to

cardiovascular, ocular and muscular diseases
does not focus on any specific organ
does not make tissue engineering with scaffolds
uses several types of stem cells
does not use gene therapy or small molecules or proteins
heavily depends on reagents and materials as well as cell and tissue sources and IT
does not provide any specific services

In combination with the evaluation done by the experts of the field, this
gap will be filled. This is our competitive advantage.

Functional modules
Publication
- article(s)
- report(s)
- PDF

Knowledge base
- terms for biotech
- terms for startups
- biotech reviews

Analytics
- expert evaluation
- fin/mng practices
- diagrams
- dashboard

Investing

Collaboration

Profiles

- fintech & legaltech

- fiat money
- cryptocurrency

- boards of experts
- evaluate project
- invest as a group

- startup
- investor
- expert
...

Blockchain &
cryptocurrency
- registry
- finance
- bonuses

6 month long project, with 2-weeks long sprints moving the project from the idea to a holistic
solution. The general principle here is to build and deploy a minimum working solution,
engage with the user, get feedback and move further.
We start with Publications with Profiles and min Collaboration on Investment next.
The current specifics may change the routing from start to the state we are aiming for.